Daiwa Securities Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
133
| – | – | ﹤0.01% | 1216 |
|
|
2025
Q1 | $1K | Hold |
133
| – | – | ﹤0.01% | 1231 |
|
|
2024
Q4 | $2K | Hold |
133
| – | – | ﹤0.01% | 1218 |
|
|
2024
Q3 | $8K | Hold |
133
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q2 | $6K | Hold |
133
| – | – | ﹤0.01% | 1182 |
|
|
2024
Q1 | $9K | Buy |
133
+22
| +20% | +$1.49K | ﹤0.01% | 1167 |
|
|
2023
Q4 | $4K | Hold |
111
| – | – | ﹤0.01% | 1216 |
|
|
2023
Q3 | $4K | Hold |
111
| – | – | ﹤0.01% | 1169 |
|
|
2023
Q2 | $4K | Hold |
111
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q1 | $5K | Hold |
111
| – | – | ﹤0.01% | 1144 |
|
|
2022
Q4 | $5K | Buy |
111
+31
| +39% | +$1.4K | ﹤0.01% | 1149 |
|
|
2022
Q3 | $3K | Hold |
80
| – | – | ﹤0.01% | 1188 |
|
|
2022
Q2 | $2K | Hold |
80
| – | – | ﹤0.01% | 1231 |
|
|
2022
Q1 | $4K | Hold |
80
| – | – | ﹤0.01% | 1189 |
|
|
2021
Q4 | $5K | Hold |
80
| – | – | ﹤0.01% | 1189 |
|
|
2021
Q3 | $3K | Buy |
80
+36
| +82% | +$1.35K | ﹤0.01% | 1211 |
|
|
2021
Q2 | $2K | Hold |
44
| – | – | ﹤0.01% | 1137 |
|
|
2021
Q1 | $3K | Hold |
44
| – | – | ﹤0.01% | 1108 |
|
|
2020
Q4 | $3K | Buy |
+44
| New | +$3K | ﹤0.01% | 1084 |
|